
Pharmaceutical Services Outsourcing Market by Service (Auditing & Assessment, Consulting, Product Design & Development), End-Use (Biotech, Pharma) - Global Forecast 2024-2030
Description
Pharmaceutical Services Outsourcing Market by Service (Auditing & Assessment, Consulting, Product Design & Development), End-Use (Biotech, Pharma) - Global Forecast 2024-2030
The Pharmaceutical Services Outsourcing Market size was estimated at USD 77.74 billion in 2023 and expected to reach USD 83.23 billion in 2024, at a CAGR 7.54% to reach USD 129.34 billion by 2030.
Global Pharmaceutical Services Outsourcing Market
FPNV Positioning Matrix
The FPNV Positioning Matrix is pivotal in evaluating the Pharmaceutical Services Outsourcing Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).
Market Share Analysis
The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Pharmaceutical Services Outsourcing Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.
Key Company Profiles
The report delves into recent significant developments in the Pharmaceutical Services Outsourcing Market, highlighting leading vendors and their innovative profiles. These include Cambrex Corporation, CareCloud, Inc., Cerner Corporation, Charles River Laboratories International, Inc., Concept Heidelberg GmbH, Eurofins Scientific SE, ICON PLC, Inspired Pharma Training Ltd., IQVIA Inc., Lachman Consultant Services, Inc., NextGen Healthcare, Inc., Parexel International Corporation, Reading Scientific Services Ltd., SGS SA, and The Quantic Group.
Market Segmentation & Coverage
This research report categorizes the Pharmaceutical Services Outsourcing Market to forecast the revenues and analyze trends in each of the following sub-markets:
Service
Auditing & Assessment
Consulting
Product Design & Development
Product Maintenance
Product Testing & Validation
Regulatory Affairs
Training & Education
End-Use
Biotech
Pharma
Region
Americas
Argentina
Brazil
Canada
Mexico
United States
California
Florida
Illinois
New York
Ohio
Pennsylvania
Texas
Asia-Pacific
Australia
China
India
Indonesia
Japan
Malaysia
Philippines
Singapore
South Korea
Taiwan
Thailand
Vietnam
Europe, Middle East & Africa
Denmark
Egypt
Finland
France
Germany
Israel
Italy
Netherlands
Nigeria
Norway
Poland
Qatar
Russia
Saudi Arabia
South Africa
Spain
Sweden
Switzerland
Turkey
United Arab Emirates
United Kingdom
The report offers valuable insights on the following aspects:
1. Market Penetration: It presents comprehensive information on the market provided by key players.
2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.
3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.
4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.
5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.
The report addresses key questions such as:
1. What is the market size and forecast of the Pharmaceutical Services Outsourcing Market?
2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Pharmaceutical Services Outsourcing Market?
3. What are the technology trends and regulatory frameworks in the Pharmaceutical Services Outsourcing Market?
4. What is the market share of the leading vendors in the Pharmaceutical Services Outsourcing Market?
5. Which modes and strategic moves are suitable for entering the Pharmaceutical Services Outsourcing Market?
Note: PDF & Excel + Online Access - 1 Year
Table of Contents
181 Pages
- 1. Preface
- 1.1. Objectives of the Study
- 1.2. Market Segmentation & Coverage
- 1.3. Years Considered for the Study
- 1.4. Currency & Pricing
- 1.5. Language
- 1.6. Limitations
- 1.7. Assumptions
- 1.8. Stakeholders
- 2. Research Methodology
- 2.1. Define: Research Objective
- 2.2. Determine: Research Design
- 2.3. Prepare: Research Instrument
- 2.4. Collect: Data Source
- 2.5. Analyze: Data Interpretation
- 2.6. Formulate: Data Verification
- 2.7. Publish: Research Report
- 2.8. Repeat: Report Update
- 3. Executive Summary
- 4. Market Overview
- 4.1. Introduction
- 4.2. Pharmaceutical Services Outsourcing Market, by Region
- 5. Market Insights
- 5.1. Market Dynamics
- 5.1.1. Drivers
- 5.1.1.1. Increasing pharmaceutical expenditure on research and development activities
- 5.1.1.2. Potential need attributed to cost and time saving in operations and management of a production & research facility
- 5.1.1.3. Growing demand from small pharmaceuticals and biotechnology companies
- 5.1.2. Restraints
- 5.1.2.1. Reduced profit margins owing to robust competition in the market
- 5.1.3. Opportunities
- 5.1.3.1. Emerging adoption of machine learning and artificial intelligence coupled with automation in drug development
- 5.1.3.2. Extensive investment in novel and therapeutic therapies such as regenerative medicine
- 5.1.4. Challenges
- 5.1.4.1. Lack of consistency in the pharmaceutical product quality
- 5.2. Market Segmentation Analysis
- 5.3. Market Trend Analysis
- 5.4. Cumulative Impact of High Inflation
- 5.5. Porter’s Five Forces Analysis
- 5.5.1. Threat of New Entrants
- 5.5.2. Threat of Substitutes
- 5.5.3. Bargaining Power of Customers
- 5.5.4. Bargaining Power of Suppliers
- 5.5.5. Industry Rivalry
- 5.6. Value Chain & Critical Path Analysis
- 5.7. Regulatory Framework
- 6. Pharmaceutical Services Outsourcing Market, by Service
- 6.1. Introduction
- 6.2. Auditing & Assessment
- 6.3. Consulting
- 6.4. Product Design & Development
- 6.5. Product Maintenance
- 6.6. Product Testing & Validation
- 6.7. Regulatory Affairs
- 6.8. Training & Education
- 7. Pharmaceutical Services Outsourcing Market, by End-Use
- 7.1. Introduction
- 7.2. Biotech
- 7.3. Pharma
- 8. Americas Pharmaceutical Services Outsourcing Market
- 8.1. Introduction
- 8.2. Argentina
- 8.3. Brazil
- 8.4. Canada
- 8.5. Mexico
- 8.6. United States
- 9. Asia-Pacific Pharmaceutical Services Outsourcing Market
- 9.1. Introduction
- 9.2. Australia
- 9.3. China
- 9.4. India
- 9.5. Indonesia
- 9.6. Japan
- 9.7. Malaysia
- 9.8. Philippines
- 9.9. Singapore
- 9.10. South Korea
- 9.11. Taiwan
- 9.12. Thailand
- 9.13. Vietnam
- 10. Europe, Middle East & Africa Pharmaceutical Services Outsourcing Market
- 10.1. Introduction
- 10.2. Denmark
- 10.3. Egypt
- 10.4. Finland
- 10.5. France
- 10.6. Germany
- 10.7. Israel
- 10.8. Italy
- 10.9. Netherlands
- 10.10. Nigeria
- 10.11. Norway
- 10.12. Poland
- 10.13. Qatar
- 10.14. Russia
- 10.15. Saudi Arabia
- 10.16. South Africa
- 10.17. Spain
- 10.18. Sweden
- 10.19. Switzerland
- 10.20. Turkey
- 10.21. United Arab Emirates
- 10.22. United Kingdom
- 11. Competitive Landscape
- 11.1. FPNV Positioning Matrix
- 11.2. Market Share Analysis, By Key Player
- 11.3. Competitive Scenario Analysis, By Key Player
- 12. Competitive Portfolio
- 12.1. Key Company Profiles
- 12.1.1. Cambrex Corporation
- 12.1.2. CareCloud, Inc.
- 12.1.3. Cerner Corporation
- 12.1.4. Charles River Laboratories International, Inc.
- 12.1.5. Concept Heidelberg GmbH
- 12.1.6. Eurofins Scientific SE
- 12.1.7. ICON PLC
- 12.1.8. Inspired Pharma Training Ltd.
- 12.1.9. IQVIA Inc.
- 12.1.10. Lachman Consultant Services, Inc.
- 12.1.11. NextGen Healthcare, Inc.
- 12.1.12. Parexel International Corporation
- 12.1.13. Reading Scientific Services Ltd.
- 12.1.14. SGS SA
- 12.1.15. The Quantic Group
- 12.2. Key Product Portfolio
- 13. Appendix
- 13.1. Discussion Guide
- 13.2. License & Pricing
- FIGURE 1. PHARMACEUTICAL SERVICES OUTSOURCING MARKET RESEARCH PROCESS
- FIGURE 2. PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, 2023 VS 2030
- FIGURE 3. PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, 2018-2030 (USD MILLION)
- FIGURE 4. PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY REGION, 2023 VS 2030 (%)
- FIGURE 5. PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 6. PHARMACEUTICAL SERVICES OUTSOURCING MARKET DYNAMICS
- FIGURE 7. PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY SERVICE, 2023 VS 2030 (%)
- FIGURE 8. PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY SERVICE, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 9. PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY END-USE, 2023 VS 2030 (%)
- FIGURE 10. PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY END-USE, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 11. AMERICAS PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
- FIGURE 12. AMERICAS PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 13. UNITED STATES PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY STATE, 2023 VS 2030 (%)
- FIGURE 14. UNITED STATES PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 15. ASIA-PACIFIC PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
- FIGURE 16. ASIA-PACIFIC PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 17. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
- FIGURE 18. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 19. PHARMACEUTICAL SERVICES OUTSOURCING MARKET, FPNV POSITIONING MATRIX, 2023
- FIGURE 20. PHARMACEUTICAL SERVICES OUTSOURCING MARKET SHARE, BY KEY PLAYER, 2023
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.